跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NM-X1
首页
药物
NM-X1
NM-X1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DITHIOLENE METAL COMPLEXES
申请人: BASF SE
优先权: 2020
CN
EP
US
WO
4 件公开
(Meth)acrylate derivative, polymer and photoresist composition having lactone structure, and method for forming pattern by using it
申请人: MAEDA KATSUMI
优先权: 2008
US
4 件公开
Method of selecting HLA-DP4 ligands and the applications thereof
申请人: COMMISSARIAT ENERGIE ATOMIQUE
优先权: 2001
US
3 件公开
Fluorescent pyrazine derivatives and methods of using the same in assessing renal function
申请人: RAJAGOPALAN RAGHAVAN
优先权: 2005
US
3 件公开
Photocurable composition and dental restoration filling material
申请人: TOKUYAMA DENTAL CORP
优先权: 2017
CN
US
2 件公开
Photoresist monomers, polymers thereof and photoresist compositons containing the same
申请人: HYNIX SEMICONDUCTOR INC
优先权: 2001
US
2 件公开
Phthalocyanine compounds, process for producing the same, and near infrared absorbent comprising the same
申请人: YAMAMOTO CHEMICALS INC
优先权: 1999
US
C5a Receptor Antagonists
申请人: JERINI AG
优先权: 2003
EP
Piperazine derivates for the inhibition of beta-secretase, cathepsin D, plasmepsin ll and HIV protease and for the treatment of malaria, Alzeheimer and AIDS
申请人: SPEEDEL EXPERIMENTA AG
优先权: 2005
EP
DENTAL FILLING REPAIRING MATERIAL
申请人: TOKUYAMA DENTAL CORP
优先权: 2012
EP
第 1 / 2 页
上一页
下一页
药物
反馈